Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Links shared publicly online about this topic.

  • 1,645
    total visits

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

jco.ascopubs.org

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

View full resource at jco.ascopubs.org

Tags: Cancer, Breast Cancer, Women's Health

  • Share

Most Recently Shared on October 27, 2009 at 10:43 pm By:

MarkRobsonMD Mark Robson

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers [Breast Cancer] http://bit.ly/DtEyI

3 years ago...

Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers - Barnes - 2012 - Journal of Internal Medicine - Wiley Online Library

onlinelibrary.wiley.com — “Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers - Barnes - 2012 - Journal of Internal Medicine - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 11:23 am By:

BreastCancer_OW Breast Cancer OW OW Health

Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic... http://t.co/DyjNCRLu

2 months ago...

Breast Cancer Research | Abstract | Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

breast-cancer-research.com — “Breastfeeding has been inversely related to breast cancer risk in the general population. Clarifying the role of breastfeeding among women with a BRCA1 or BRCA2 mutation may be helpful for risk assessment and for recommendations regarding prevention. We present an updated analysis of breastfeeding and risk of breast cancer using a large matched sample of BRCA mutation carriers.View full resource at breast-cancer-research.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 3:25 pm By:

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review

hindawi.com — “Individuals who carry an inherited mutation in the breast cancer 1 (BRCA1) and BRCA2 genes have a significant risk of developing breast and ovarian cancer over the course of their lifetime. As a result, there are important considerations for the clinician in the counseling, followup and management of mutation carriers. This review outlines salient aspects in the approach to patients at high risk of developing breast and ovarian cancer, including criteria for genetic testing, screening guidelinesView full resource at hindawi.com

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 11:02 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review: Individuals who carry an inherited muta... http://bit.ly/nhCS0W

9 months ago...

Oncology Article | Breast cancer

mdlinx.com — “Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriersView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 29, 2011 at 3:25 pm By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: British Journal of Cancer http://bit.ly/jLSNA9 #oncology

1 year ago...

Oncology Article | Breast Neoplasms

mdlinx.com — “Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 11, 2011 at 5:31 am By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy... http://bit.ly/eQ5gQk #oncology

1 year ago...

JAMA -- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality, September 1, 2010, Domchek et al. 304 (9): 967

jama.ama-assn.org — “JAMA is a highly cited weekly medical journal that publishes peer-reviewed original medical research findings and editorial opinionView full resource at jama.ama-assn.org

  • View Related
  • Share

Most Recently Shared on September 1, 2010 at 8:43 pm By:

JAMA_current JAMA Medical Journal

Preventive Breast or Ovarian Surgery Associated with Lower Risk of Cancer for Women with BRCA 1 or 2 Mutations http://bit.ly/aKbaHL

2 years ago...

Susan G. Komen for the Cure | Understanding Breast Cancer | Risk Factors and Prevention | Family History & Genetic Risks | Inherited Genetic Mutations

ww5.komen.org — “Download Genetics and Breast Cancer PDF, 124KB A number of inherited mutations have been linked to breast cancer, including mutations in the following genes: BRCA1, BRCA2, p53 and PTEN/ MMAC1. Other gView full resource at ww5.komen.org

  • View Related
  • Share

Most Recently Shared on July 7, 2010 at 4:06 pm By:

komenforthecure Komen for the Cure Health Organization

Bloomberg: #BreastCancer Gene Hits Men Causes Tumors for 1 in 12 carriers http://bit.ly/aCRdMm Learn about GeneMutation http://bit.ly/bOeTcj

2 years ago...

Oncology Medical News about Alcohol Drinking Breast Neoplasms Risk

mdlinx.com — “Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriersView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 16, 2010 at 4:02 pm By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers: The Breast http://bit.ly/d0cQgi #oncology

2 years ago...

Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2

jco.ascopubs.org — “Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2View full resource at jco.ascopubs.org

  • View Related
  • Share

Most Recently Shared on April 9, 2010 at 12:22 am By:

MarkRobsonMD Mark Robson Hematologist, Physician, Doctor, Internist, and Oncologist

JCO: Population-Based Study BRCA1/2 Second Primary Contralateral Breast Cancer http://bit.ly/dpcpnr

2 years ago...

Oncology Medical News about BRCA1 Protein BRCA2 Protein Breast Neoplasms

mdlinx.com — “Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2View full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 8, 2010 at 7:04 am By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Population-based study of the risk of second primary contralateral breast cancer associated with carrying... http://bit.ly/be5tCq #oncology

2 years ago...

Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach - Fu - 2007 - Statistics in Medicine - Wiley Online Library

onlinelibrary.wiley.com — “Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach - Fu - 2007 - Statistics in Medicine - Wiley Online LibraryView full resource at onlinelibrary.wiley.com

  • View Related
  • Share

Most Recently Shared on November 18, 2009 at 2:32 am By:

MarkRobsonMD Mark Robson Hematologist, Physician, Doctor, Internist, and Oncologist

Low estimates: Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach http://bit.ly/2NJULV

2 years ago...

British Journal of Cancer - Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

nature.com — “The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial iView full resource at nature.com

  • View Related
  • Share

Most Recently Shared on November 18, 2009 at 2:17 am By:

MarkRobsonMD Mark Robson Hematologist, Physician, Doctor, Internist, and Oncologist

Evaluation of a SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers (CIMBA). http://bit.ly/4bO6TQ

2 years ago...

Advertisement